These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 116360)

  • 1. [The hypocalcemia test, using human and salmon synthetic calcitonins. Paradoxical hypercalcemic responses. Responses in patients with Paget's disease treated with EHDP].
    Alexandre C; Chapuy MC; Meunier P
    Rev Rhum Mal Osteoartic; 1979 May; 46(5):335-42. PubMed ID: 116360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A test for acute hypocalcemia using swine and salmon calcitonin].
    Fournié A; Valverde C; Tap G; Bazerque JJ; Ayrolles C
    Rev Rhum Mal Osteoartic; 1977 Feb; 44(2):91-8. PubMed ID: 847364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.
    Haddad JG; Caldwell JG
    J Clin Invest; 1972 Dec; 51(12):3133-41. PubMed ID: 4674398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].
    Caniggia A; Nuti R; Vattimo A; Galli M; Turchetti V; Franci B; Martorelli T; Righi G
    Minerva Med; 1983 Apr; 74(18):993-1010. PubMed ID: 6087215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic human calcitonin in refractory Paget's disease of bone.
    Altman RD; Collins-Yudiskas B
    Arch Intern Med; 1987 Jul; 147(7):1305-8. PubMed ID: 3111398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC; Meunier P; Terrier M; David L; Vignon G
    Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic sequences calcitonin-EHDP and EHDP-calcitonin in Paget's disease. Histological and biological study].
    Eisinger J; Laponche AM; Ouaniche J
    Rev Rhum Mal Osteoartic; 1986 Mar; 53(3):183-5. PubMed ID: 3085204
    [No Abstract]   [Full Text] [Related]  

  • 8. Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
    Delmas PD; Chapuy MC; Meunier PJ
    Horm Metab Res; 1984 May; 16(5):258-61. PubMed ID: 6234216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of the calcitonin test in Paget's disease of bone].
    D'Amore M; Bozzi A; Telesca ML; Carrozzo M
    Minerva Med; 1981 Apr; 72(14):865-8. PubMed ID: 7219796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC; Harrison JE; Wilson DR
    Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis, osteomalacia, rickets, and Paget's disease.
    Nugent CA; Gall EP; Pitt MJ
    Prim Care; 1984 Jun; 11(2):353-68. PubMed ID: 6236469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Induced hypocalcaemia test using salmon calcitonin as a means for the evaluation of osteoclastic activity (author's transl)].
    Blanc D; Chapuy MC; Meunier P
    Nouv Presse Med; 1977 Aug 27-Sep 3; 6(28):2489-94. PubMed ID: 562508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Test for hypocalcemia due to calcitonin in the normal subject and in patients with osteoporosis or Paget's disease. Preliminary results].
    Renier JC; Bernat M; Brégeon C; Gallois Y; Rebel A; Basle M; Auvinet B; Pitois M
    Rev Rhum Mal Osteoartic; 1975 Dec; 42(12):731-7. PubMed ID: 1224158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of Paget's disease].
    Audran M; Baslé MF
    Rev Prat; 1989 Apr; 39(13):1137-42. PubMed ID: 2525271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
    Nuti R; Turchetti V; Righi G; Vattimo A
    Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    De Vries HR; Bijvoet OL
    Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Paget's disease with salmon calcitonin].
    Manderlier T; Fuss M; Brauman J; Orloff S; Bergans A; Corvilain J
    Rev Rhum Mal Osteoartic; 1977 Jan; 44(1):59-66. PubMed ID: 319520
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic effect of synthetic calcitonin from salmon in Paget's disease and in osteoporosis].
    Caniggia A; Gennari C; Vattimo A; Nardi P; Francini G
    Clin Ter; 1977 Aug; 82(3):213-26. PubMed ID: 562244
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of the therapeutic sequence calcitonin-EHDP in Paget's disease].
    Eisinger J; Schiano A; d'Omezon Y; Ouaniche J
    Rev Rhum Mal Osteoartic; 1983 Mar; 50(3):245-6. PubMed ID: 6408727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.